The posting
The development of lifesaving vaccines and treatments for infectious diseases is increasingly hindered by the surging cost and difficulty of generating high-quality evidence in humans through clinical trials. 1Day Sooner is working to change that through “Clinical Trial Abundance (CTA)," a national advocacy campaign to reduce the cost of health evidence and extract more value from the evidence we have. As Director, Science Policy and Advocacy, you will lead the CTA program and drive progress...



